APONTIS PHARMA
Edit

APONTIS PHARMA

https://apontis-pharma.de/
Last activity: 14.12.2021
Active
Categories: DevelopmentMedtechSalesSpecialtySupply
Der Name ist neu, die Qualität unserer Arbeit seit mehr als 70 J. einzigartig: gegründet 1946 als SCHWARZ PHARMA, erreichten wir unter diesem Namen einen hohen Bekanntheitsgrad, den wir kontinuierlich ausbauen.
Mentions
15
Location: Germany, North Rhine-Westphalia, Kerpen

Investors 1

DateNameWebsite
-Paragon Pa...paragon.de

Mentions in press and media 15

DateTitleDescription
14.12.2021APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rightsDGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch/Alliance APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights 14.12.2021 / 07:30 The issuer is solel...
18.11.2021APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Revenue forecast increasedDGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/9 Month figures APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Revenue forecast increased 18.11.2021 / 07:30 The is...
26.10.2021PRESS RELEASE : APONTIS PHARMA announces market launch of new Single PillDGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA announces market launch of new Single Pill 2021-10-26 / 07:30 The issuer is solely responsible for the content of this announcement. ---------------------------------...
26.10.2021APONTIS PHARMA : announces market launch of new Single PillDGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA announces market launch of new Single Pill 26.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement. APONTIS PHARMA announces market l...
14.09.2021APONTIS PHARMA : announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemiaDGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia 14.09.2021 / 07:30 The issuer is solely responsible for the conten...
14.09.2021PRESS RELEASE : APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemiaDGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia 2021-09-14 / 07:30 The issuer is solely responsible for the conten...
14.08.2021PRESS RELEASE : APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmedDGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmed 2021-08-11 / 07:30 The issuer is so...
11.08.2021PRESS RELEASE : APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmedDGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmed 2021-08-11 / 07:30 The issuer is so...
11.08.2021APONTIS PHARMA : builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmedDGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmed 11.08.2021 / 07:30 The issuer is so...
12.07.2021PRESS RELEASE : APONTIS PHARMA marks further success in the roll-out of Single Pill therapyDGAP-News: APONTIS PHARMA AG / Key word(s): Alliance APONTIS PHARMA marks further success in the roll-out of Single Pill therapy 2021-07-12 / 07:30 The issuer is solely responsible for the content of this announcement. =--------------------...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In